−0.179SEK
−95.27 MSEK
97.51 MSEK
349.05 M
About INDEX PHARMACEUTICALS HOLDING AB
Sector
CEO
Jenny Sundqvist
Headquarters
Solna
Website
Employees (FY)
7
Founded
2016
ISIN
SE0008966295
FIGI
BBG00DZ9N1S5
InDex Pharmaceuticals Holding AB engages in the development of drugs for the treatment of diseases such as inflammation and cancer. It conducts research, technology development, and commercialization of scientific discoveries in the biomedical field. The company was founded by Oliver von Stein and Svante Rasmuson in 2000 and is headquartered in Stockholm, Sweden.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of INDEX is 0.32 SEK — it has decreased by 0.61% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange INDEX PHARMACEUTICALS HOLDING AB stocks are traded under the ticker INDEX.
INDEX PHARMACEUTICALS HOLDING AB is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.
Yes, you can track INDEX PHARMACEUTICALS HOLDING AB financials in yearly and quarterly reports right on TradingView.
INDEX stock has fallen by 2.70% compared to the previous week, the month change is a 12.89% rise, over the last year INDEX PHARMACEUTICALS HOLDING AB has showed a 22.49% decrease.
Like other stocks, INDEX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade INDEX PHARMACEUTICALS HOLDING AB stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 7.00 employees. See our rating of the largest employees — is INDEX PHARMACEUTICALS HOLDING AB on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. INDEX PHARMACEUTICALS HOLDING AB EBITDA is −94.49 M SEK, and current EBITDA margin is −96.91%. See more stats in INDEX PHARMACEUTICALS HOLDING AB financial statements.